Clinical Trial Update: Neurostimulation to Treat Refractory Angina Pectoris Pain [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating neurostimulation to treat refractory angina pectoris was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris

Drugs mentioned

• Neurostimulation device therapy for refractory angina

Snippet

Sponsor: MedtronicNeuro | Conditions: Angina Pectoris | Phase 3 | Status: TERMINATED